FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.
Also STAR trial can be completed with fewer women than planned, NSABP says.
NCCF, Ad Council plan public service ads on childhood cancer.
MSKCC hopes to raise $1 billion in five-year campaign.
